Phosphorylation of tyrosine 107 can give the cleavage of galectin-3, and the ratio of phosphorylated/dephosphorylated galectin-3 can be used for the prognosis of prostate cancer as well as be a target for potential treatment [43]. Here, LGALS3 is linked to prostate carcinoma.